Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.5B | 15.0B | 14.3B | 14.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.6B | 6.6B | 7.0B | 6.7B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.5B | 4.9B | 4.2B | 4.1B |
Tax provision | 1.2B | 1.2B | 995M | 957M |
Net income | 4.4B | 3.7B | 3.2B | 3.1B |
Basic EPS | 2.6 | 2.3 | 1.9 | 1.9 |
Diluted EPS | 2.6 | 2.2 | 1.9 | 1.8 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | — | — | — | — |
Net income from continuing op. | 4.4B | 3.7B | 3.2B | 3.1B |
Minority interests | -56M | -10M | -38M | -41M |
Preferred stock dividends | — | — | — | — |